---
title: "BGI Genomics shareholder BGI Holdings intends to inquire about the transfer of 4% of the company's shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257101099.md"
description: "According to the Zhitong Finance APP, BGI Genomics has released a shareholder inquiry transfer plan. The shareholder participating in the inquiry transfer is Shenzhen BGI Technology Co., Ltd. (hereinafter referred to as BGI Holdings or the transferor), which intends to transfer a total of 16.7327 million shares, accounting for 4.00% of the company's total share capital"
datetime: "2025-09-12T11:54:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257101099.md)
  - [en](https://longbridge.com/en/news/257101099.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257101099.md)
generator: "portal-rs"
---

# BGI Genomics shareholder BGI Holdings intends to inquire about the transfer of 4% of the company's shares

According to the Zhitong Finance APP, BGI Genomics (300676.SZ) has released a shareholder inquiry transfer plan. The shareholder participating in the inquiry transfer is Shenzhen BGI Technology Co., Ltd. (hereinafter referred to as BGI Holdings or the transferor), which intends to transfer a total of 16.7327 million shares, accounting for 4.00% of the company's total share capital

### Related Stocks

- [300676.CN](https://longbridge.com/en/quote/300676.CN.md)

## Related News & Research

- [North Sea Crude-WTI weakens on lower offer](https://longbridge.com/en/news/296813963.md)
- [Nimiq Opens Second Mini Apps Competition After Strong Debut](https://longbridge.com/en/news/297184111.md)
- [Sugar Prices Consolidate Below Last Week’s Significant Highs](https://longbridge.com/en/news/296819776.md)
- [LB Group : Revenue up 8.15% but net profit down 39.08% amid cost pressures and major share buyback](https://longbridge.com/en/news/297034690.md)
- [aXichem expects EU approval for phenylcapsaicin poultry-feed additive by end-2026 after positive EFSA opinion](https://longbridge.com/en/news/297133788.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**